Orchid Pharma gets EIR from USFDA for Tamil Nadu plant

18 Apr 2017 Evaluate

Orchid Pharma has received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection of the formulation manufacturing facility located at Plot Nos B5 (Pt) & B6 (Pt), SIPCOT Industrial Park, Irungattukottai, Sriperumbudur, Kancheepuram District in Tamil Nadu, India. The facility was inspected by USFDA in December 2016.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.

Orchid Pharma Share Price

761.60 -9.00 (-1.17%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×